This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddy, J. K. Articles by Qureshi, S. A. Search for Related Content PubMed PubMed Citation Articles by Reddy, J. K. Articles by Qureshi, S. A.

Excessive Accumulation of Autofluorescent Lipofuscin in the Liver during Hepatocarcinogenesis by Methyl Clofenapate and Other Hypolipidemic Peroxisome Proliferators¹

Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611

Several hypolipidemic drugs and certain industrial plasticizers induce proliferation of peroxisomes and enhance the activities of peroxisome-associated enzymes in the livers of rodents. Evidence now suggests that potent hepatic peroxisome proliferators as a class are carcinogenic, although they do not appear to be mutagenic in the Salmonella-microsome assay system. We now report that long-term administration of methyl-2[4-(p-chlorophenyl)phenoxy]-2-methylpropionate, a potent hepatic peroxisome proliferator, at a dietary concentration of 0.1% (w/w), induced hepatocellular carcinomas in 14 of 14 male F344 rats between 65 and 75 weeks. The tumor cells contained several peroxisomes. Consistent with this observation was the finding of increased levels of carnitine acetyltransferase, heat-labile peroxisomal enoyl coenzyme hydratase, and peroxisomal ß-oxidation system in the tumors.

As expected, methyl clofenapate was not mutagenic in the Salmonella-microsome assay using Salmonella typhimurium strains TA98 and TA100.

Abundant accumulation of autofluorescent lipofuscin in the nontumorous portions of liver in rats bearing methyl-2-[4-(p-chlorophenyl)phenoxy]-2-methylpropionate-induced hepatocellular carcinomas was observed. The examination in this study of livers of rats bearing hepatocellular carcinomas induced previously by five other hypolipidemic peroxisome proliferators provided retrospective evidence for increased accumulation of autofluorescent pigment in the liver cells. It is suggested that accumulation of lipofuscin in the livers of rats fed peroxisome proliferators serves as evidence for the increased production of biologically damaging free radicals as a result of H₂O₂ generated by sustained proliferation of peroxisomes. The hypothesis that persistent proliferation of peroxisomes and increase in peroxisomal ß-oxidation system serves as endogenous initiator of the neoplastic transformation of liver cells by increasing the intracellular production of DNA-damaging H₂O₂ and other reactive oxygen intermediates (OH·, O₂^T, ¹O₂) remains to be tested.

¹ Supported in part by NIH Research Grant GM-23750 and the Department of Pathology, Northwestern University Medical School.

² To whom requests for reprints should be addressed, at the Department of Pathology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, III. 60611.

Received 6/ 5/81. Accepted 10/14/81.

This article has been cited by other articles:

				J. Nishimura, Y. Dewa, T. Okamura, M. Jin, Y. Saegusa, M. Kawai, T. Umemura, M. Shibutani, and K. Mitsumori Role of Nrf2 and Oxidative stress on Fenofibrate-Induced Hepatocarcinogenesis in Rats Toxicol. Sci., December 1, 2008; 106(2): 339 - 349. [Abstract] [Full Text] [PDF]

				J. K. Reddy Peroxisome Proliferators and Peroxisome Proliferator-Activated Receptor {alpha}: Biotic and Xenobiotic Sensing Am. J. Pathol., June 1, 2004; 164(6): 2305 - 2321. [Full Text] [PDF]

				J. C. Tharappel, A. Nalca, A. B. Owens, L. Ghabrial, E. C. Konz, H. P. Glauert, and B. T. Spear Cell Proliferation and Apoptosis Are Altered in Mice Deficient in the NF-{kappa}B p50 Subunit after Treatment with the Peroxisome Proliferator Ciprofibrate Toxicol. Sci., October 1, 2003; 75(2): 300 - 308. [Abstract] [Full Text] [PDF]

				K. Meyer, J.-S. Lee, P. A. Dyck, W.-Q. Cao, M.S. Rao, S. S. Thorgeirsson, and J. K. Reddy Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen Carcinogenesis, May 1, 2003; 24(5): 975 - 984. [Abstract] [Full Text] [PDF]

				M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643 Carcinogenesis, April 1, 2003; 24(4): 757 - 770. [Abstract] [Full Text] [PDF]

				M. L. O'Brien, M. L. Cunningham, B. T. Spear, and H. P. Glauert Peroxisome Proliferators Do Not Activate the Transcription Factors AP-1, Early Growth Response-1, or Heat Shock Factors 1 and 2 in Rats or Hamsters Toxicol. Sci., September 1, 2002; 69(1): 139 - 148. [Abstract] [Full Text] [PDF]

				J E Klaunig, L M Kamendulis, and Y. Xu Epigenetic mechanisms of chemical carcinogenesis Human and Experimental Toxicology, October 1, 2000; 19(10): 543 - 555. [Abstract] [PDF]

				S. C. Hasmall and R. A. Roberts The Nongenotoxic Hepatocarcinogens Diethylhexylphthalate and Methylclofenapate Induce DNA Synthesis Preferentially in Octoploid Rat Hepatocytes Toxicol Pathol, July 1, 2000; 28(4): 503 - 509. [Abstract] [PDF]

				C. Metzger, D. Mayer, H. Hoffmann, T. Bocker, G. Hobe, A. Benner, and P. Bannasch Sequential Appearance and Ultrastructure of Amphophilic Cell Foci, Adenomas, and Carcinomas in the Liver of Male and Female Rats Treated with Dehydroepiandrosterone Toxicol Pathol, September 1, 1995; 23(5): 591 - 605. [Abstract] [PDF]

				J. R Foster Peroxisomes without catalase: More evidence for the active oxygen hypothesis?: Catalase-negative peroxisomes: Transient appear ance in rat hepatocytes during liver regeneration after partial hepatectomy Oikawa I and Novikoff PM. American Journal of Pathology 1995; 146: 673-687 Human and Experimental Toxicology, August 1, 1995; 14(8): 698 - 699. [PDF]

				J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, and I.F.H. Purchase Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis Human and Experimental Toxicology, January 1, 1994; 13(2_suppl): S1 - S117. [PDF]

				E. D. Barber, B. D. Astill, E. J. Moran, B. F. Schneider, T. J.B. Gray, B. G. Lake, and J. G. Evans Peroxisome Induction Studies On Seven Phthalate Esters Toxicology and Industrial Health, January 1, 1987; 3(2): 7 - 24. [Abstract] [PDF]

				B. E. Butterworth, D. J. Loury, T. Smith-Oliver, and R. C. Cattley The Potential Role of Chemically Induced Hyperplasia in the Carcinogenic Activity of the Hypolipidemic Carcinogens Toxicology and Industrial Health, January 1, 1987; 3(2): 129 - 149. [Abstract] [PDF]

				M. I. R. Perera, J. M. Betschart, M. A. Virji, S. L. Katyal, and H. Shinozuka Free Radical Injury and Liver Tumor Promotion Toxicol Pathol, January 1, 1987; 15(1): 51 - 59. [Abstract] [PDF]

				J. K. Reddy, D. G. Scarpelli, V. Subbarao, and N. D. Lalwani Chemical Carcinogens Without Mutagenic Activity: Peroxisome Proliferators As A Prototype Toxicol Pathol, February 1, 1983; 11(2): 172 - 180. [Abstract] [PDF]

				N. D. Lalwani, M. Kumudavalli Reddy, S. A. Qureshi, C. R. Sirtori, Y. Abiko, and J. K. Reddy Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver Human and Experimental Toxicology, January 1, 1983; 2(1): 27 - 48. [Abstract] [PDF]

				M.K. Reddy, N.D. Lalwani, S.A. Qureshi, and J.K. Reddy Induction of Hamster Hepatic Peroxisomal {beta}-oxidation and Peroxisome Proliferation-associated 80000 mol. wt. Polypeptide by Hypolipidemic Drugs Human and Experimental Toxicology, March 1, 1982; 1(2): 135 - 147. [Abstract] [PDF]